FDA device listing
Atellica CH Glucose Hexokinase_3 (GluH_3)
FDA device listing 1624811658 · RANDOX LABORATORIES, LTD.
Key facts
| Proprietary names | Atellica CH Glucose Hexokinase_3 (GluH_3) |
|---|---|
| Owner/operator | RANDOX LABORATORIES, LTD. |
| Owner/operator number | 8020890 |
| Product codes | CFR |
| Device names | CFR - Hexokinase, Glucose |
| Device class | Class II |
| Classification regulations (21 CFR) | 862.1345 |
| Review panels | Clinical Chemistry |
| Registered establishments | RANDOX LABORATORIES LIMITED |
| Establishment registrations | 3004493545 |
| FEI numbers | 3004493545 |
| Establishment operations | Contract Manufacturer |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- None listed Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database